BridgeMD
New treatment option for Breast Cancer
Official title Breast Mesh Used in Two-staged Breast Reconstruction
ClinicalTrials.gov ID: NCT04967976
What this study is testing
- What it's testing
- This is the first prospective randomized and controlled study on the efficacy and safety of TiLOOP® Bra mesh in patients with expander-implant breast reconstruction. The investigators hypothesize that incoporating TiLOOP Bra mesh with tissue expanders will reduce the rates of capsular contraction, improve the efficiency of expansion and provide better aesthetic result.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70, women only
You may be able to join if
- Diagnosed with breast cancer
- More than 18 years old
- Karnofsky Performance Status (KPS) larger than 80
- No clinical or imaging evidence of distant metastasis
- BMI \< 35kg/m2
You likely can't join if
- 1\. Patients with distant metastasis of breast cancer or local recurrence; 2. Past ipsilateral breast/chest wall radiation; 3. Inflammatory breast...
See the full eligibility criteria
- Diagnosed with breast cancer
- More than 18 years old
- Karnofsky Performance Status (KPS) larger than 80
- No clinical or imaging evidence of distant metastasis
- BMI \< 35kg/m2
- Patients with no or mild breast ptosis
- No severe deficiency in hematological, cardiovascular system, no immune-deficiency, no severe abnormal liver or kidney function.
- Mental Health Patient \-
- 1\. Patients with distant metastasis of breast cancer or local recurrence; 2. Past ipsilateral breast/chest wall radiation; 3. Inflammatory breast cancer, stage IV breast cancer 4. History of severe allergic or specific...
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
- Lanzhou, Gansu, China
- Ch’ang-ch’un, Jilin, China
- Tianjin, Tianjin Municipality, China
- Hangzhou, Zhejiang, China
- Munich, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States; Lanzhou, Gansu, China; Ch’ang-ch’un, Jilin, China; Tianjin, Tianjin Municipality, China; Hangzhou, Zhejiang, China; Munich, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.